Precision health in Alzheimer disease: Risk assessment‐based strategies

Abstract Alzheimer disease (AD) is a chronic neurodegenerative condition that affects an individual's cognitive function over an extended period. Treatment and prevention for AD have long been sought after; however, no strategy has yet been successful, as individuals with cognitive impairment u...

Full description

Bibliographic Details
Main Authors: Jihan Azar, Mohamed Salama, Saravana Babu Chidambaram, Buthaina Al‐Balushi, Musthafa Mohamed Essa, M. Walid Qoronfleh
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Precision Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/prm2.12036
_version_ 1818863173767266304
author Jihan Azar
Mohamed Salama
Saravana Babu Chidambaram
Buthaina Al‐Balushi
Musthafa Mohamed Essa
M. Walid Qoronfleh
author_facet Jihan Azar
Mohamed Salama
Saravana Babu Chidambaram
Buthaina Al‐Balushi
Musthafa Mohamed Essa
M. Walid Qoronfleh
author_sort Jihan Azar
collection DOAJ
description Abstract Alzheimer disease (AD) is a chronic neurodegenerative condition that affects an individual's cognitive function over an extended period. Treatment and prevention for AD have long been sought after; however, no strategy has yet been successful, as individuals with cognitive impairment usually present to the clinic when they have reached an advanced stage of the disease. The disease is progressive and multifactorial in its pathogenesis. Precision medicine (PM) is the new era of medicine comprising a holistic approach in dealing with diseases. With scientific innovations, PM has improved our disease knowledge, altered diagnoses and therapy approaches resulting in a more precise, predictive, preventative and personalized patient care. PM in AD focuses, among other things, on stratifying individuals according to their risk factors of developing the disease and applying preventative strategies and personalized treatment approaches for a better outcome. In this mini‐review, we have focused on a few modifiable and non‐modifiable risk factors and presented recommendations for future consideration to implement.
first_indexed 2024-12-19T10:11:33Z
format Article
id doaj.art-94da07c050d14b23bdcb09eff53542ab
institution Directory Open Access Journal
issn 2642-2514
language English
last_indexed 2024-12-19T10:11:33Z
publishDate 2021-06-01
publisher Wiley
record_format Article
series Precision Medical Sciences
spelling doaj.art-94da07c050d14b23bdcb09eff53542ab2022-12-21T20:26:21ZengWileyPrecision Medical Sciences2642-25142021-06-01102547010.1002/prm2.12036Precision health in Alzheimer disease: Risk assessment‐based strategiesJihan Azar0Mohamed Salama1Saravana Babu Chidambaram2Buthaina Al‐Balushi3Musthafa Mohamed Essa4M. Walid Qoronfleh5Institute of Global Health and Human Ecology (I‐GHHE) The American University in Cairo (AUC) Cairo EgyptInstitute of Global Health and Human Ecology (I‐GHHE) The American University in Cairo (AUC) Cairo EgyptDepartment of Pharmacology JSS College of Pharmacy, JSS Academy of Higher Education & Research Mysuru IndiaDepartment of Food Science and Nutrition CAMS, Sultan Qaboos University Muscat OmanDepartment of Food Science and Nutrition CAMS, Sultan Qaboos University Muscat OmanQ3CG Research Institute (QRI) Research & Policy Division Ypsilanti Michigan USAAbstract Alzheimer disease (AD) is a chronic neurodegenerative condition that affects an individual's cognitive function over an extended period. Treatment and prevention for AD have long been sought after; however, no strategy has yet been successful, as individuals with cognitive impairment usually present to the clinic when they have reached an advanced stage of the disease. The disease is progressive and multifactorial in its pathogenesis. Precision medicine (PM) is the new era of medicine comprising a holistic approach in dealing with diseases. With scientific innovations, PM has improved our disease knowledge, altered diagnoses and therapy approaches resulting in a more precise, predictive, preventative and personalized patient care. PM in AD focuses, among other things, on stratifying individuals according to their risk factors of developing the disease and applying preventative strategies and personalized treatment approaches for a better outcome. In this mini‐review, we have focused on a few modifiable and non‐modifiable risk factors and presented recommendations for future consideration to implement.https://doi.org/10.1002/prm2.12036Alzheimer diseasedementialifestyle medicinepersonalized healthcareprecision medicineprevention
spellingShingle Jihan Azar
Mohamed Salama
Saravana Babu Chidambaram
Buthaina Al‐Balushi
Musthafa Mohamed Essa
M. Walid Qoronfleh
Precision health in Alzheimer disease: Risk assessment‐based strategies
Precision Medical Sciences
Alzheimer disease
dementia
lifestyle medicine
personalized healthcare
precision medicine
prevention
title Precision health in Alzheimer disease: Risk assessment‐based strategies
title_full Precision health in Alzheimer disease: Risk assessment‐based strategies
title_fullStr Precision health in Alzheimer disease: Risk assessment‐based strategies
title_full_unstemmed Precision health in Alzheimer disease: Risk assessment‐based strategies
title_short Precision health in Alzheimer disease: Risk assessment‐based strategies
title_sort precision health in alzheimer disease risk assessment based strategies
topic Alzheimer disease
dementia
lifestyle medicine
personalized healthcare
precision medicine
prevention
url https://doi.org/10.1002/prm2.12036
work_keys_str_mv AT jihanazar precisionhealthinalzheimerdiseaseriskassessmentbasedstrategies
AT mohamedsalama precisionhealthinalzheimerdiseaseriskassessmentbasedstrategies
AT saravanababuchidambaram precisionhealthinalzheimerdiseaseriskassessmentbasedstrategies
AT buthainaalbalushi precisionhealthinalzheimerdiseaseriskassessmentbasedstrategies
AT musthafamohamedessa precisionhealthinalzheimerdiseaseriskassessmentbasedstrategies
AT mwalidqoronfleh precisionhealthinalzheimerdiseaseriskassessmentbasedstrategies